Role of Drp1, a key mitochondrial fission protein, in neuropathic pain

Journal of Neuroscience

Volumn 31, Issue 31, 2011, Pages 11404-11410

  Ferrari, Luiz F ^a   Chum, Adrienne ^a   Bogen, Oliver ^a   Reichling, David B ^a   Levine, Jon D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GUANOSINE TRIPHOSPHATASE; HYDROGEN PEROXIDE; MDIVI 1; NEURITE PROMOTING FACTOR; NITRIC OXIDE; OXALIPLATIN; PROTEIN DRP1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZALCITABINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; MALE; MECHANICAL STIMULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNAMINS; EPINEPHRINE; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HYDROGEN PEROXIDE; HYPERALGESIA; MALE; NERVE GROWTH FACTOR; NEURALGIA; NITRIC OXIDE DONORS; NITRO COMPOUNDS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; ORGANOPLATINUM COMPOUNDS; PAIN MEASUREMENT; QUINAZOLINONES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; ZALCITABINE;

EID: 79961238706     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2223-11.2011     Document Type: Article

References (76)

1. Aley KO, McCarter G, Levine JD (1998) Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci 18:7008-7014
2. Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, Kalofonos HP (2006) Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manage 32:237-244
3. Bailey SM (2003) A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial dysfunction. Free Radic Res 37:585-596
4. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Gräber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, Bossy-Wetzel E (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25:3900-3911.
5. Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, Richman D, SooW (1993) 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 43:358-362.
6. Besse JL, Gadeyne S, Galand-Desmé S, Lerat JL, Moyen B (2009) Effect of vitaminCon prevention of complex regional pain syndrome type I in foot and ankle surgery. Foot Ankle Surg 15:179-182
7. Bogen O, Joseph EK, Chen X, Levine JD (2008) GDNF hyperalgesia is mediated by PLCgamma, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican. Eur J Neurosci 28:12-19
8. Brand MD (2010) The sites and topology of mitochondrial superoxide production. Exp Gerontol 45:466-472
9. Brooks C, Wei Q, Cho SG, Dong Z (2009) Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 119:1275-1285
10. Bureković A, Terzić M, Alajbegović S, Vukojević Z, Hadzić N (2008) The role of alpha-lipoic acid in diabetic polyneuropathy treatment. Bosn J Basic Med Sci 8:341-345
11. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR, Nunnari J (2008) Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bakdependent mitochondrial outer membrane permeabilization. Dev Cell 14:193-204
12. Chen H, Chan DC (2009) Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18:R169-R176
13. Chen JY, Chang CY, Feng PH, Chu CC, So EC, Hu ML (2009) Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain 25:562-569
14. Cheng C, Zochodne DW (2003) Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52:2363-2371
15. Dalakas MC (2001) Peripheral neuropathy and antiretroviral drugs. J Peripher Nerv Syst 6:14-20.
16. Ferrari LF, Levine JD (2010) Alcohol consumption enhances antiretroviralpainful peripheral neuropathy by mitochondrial mechanisms. Eur J Neurosci 32:811-818.
17. Ferrari LF, Bogen O, Levine JD (2010) Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience 165:896-901.
18. Flatters SJ, Bennett GJ (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122:245-257
19. Foster TS (2007) Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ 33:111-117
20. Gamelin E, Gamelin L, Bossi L, Quasthoff S (2002) Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 29 [Suppl 15]:21-33
21. Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, Frampton CM, Taylor KM, Smith RA, Murphy MP (2010) The mitochondriatargeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 30:1019-1026.
22. Gogvadze V, Orrenius S, Zhivotovsky B (2009) Mitochondria as targets for chemotherapy. Apoptosis 14:624-640
23. Green K, Brand MD, Murphy MP (2004) Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 [Suppl 1]:S110-S118.
24. Huang R, Wallqvist A, Covell DG (2005) Anticancer metal compounds in NCI's tumor-screening database: putative mode of action. Biochem Pharmacol 69:1009-1039.
25. Inoue M, Sato EF, Nishikawa M, Park AM, Kira Y, Imada I, Utsumi K (2003) Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 10:2495-2505
26. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253-265
27. Joseph EK, Levine JD (2006) Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 121:105-114
28. Joseph EK, Levine JD (2009) Comparison of oxaliplatin-and cisplatininduced painful peripheral neuropathy in the rat. J Pain 10:534-541.
29. Joseph EK, Levine JD (2010) Multiple PKCepsilon-dependent mechanisms mediating mechanical hyperalgesia. Pain 150:17-21
30. Joseph EK, Chen X, Khasar SG, Levine JD (2004) Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107:147-158
31. Joseph EK, Chen X, Bogen O, Levine JD (2008) Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9:463-472.
32. Kallianpur AR, Hulgan T (2009) Pharmacogenetics of nucleoside reversetranscriptase inhibitor-associated peripheral neuropathy. Pharmacogenomics 10:623-637.
33. Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573-584
34. Kim S, Lee TJ, Park JW, Kwon TK (2008) Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells. J Cell Biochem 105:971-979
35. Lackner LL, Nunnari J (2010) Small molecule inhibitors of mitochondrial division: tools that translate basic biological research into medicine. Chem Biol 17:578-583.
36. Leene W, Roholl PJ, de Groot C (1976) Lymphocyte differentiation in the rabbit thymus. Ann Immunol (Paris) 127:911-921
37. Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29:387-392
38. Li J, Zhou J, Li Y, Qin D, Li P (2010a) Mitochondrial fission controls DNA fragmentation by regulating endonuclease G. Free Radic Biol Med 49:622-631.
39. Li J, Li Y, Qin D, von Harsdorf R, Li P (2010b) Mitochondrial fission leads to Smac/DIABLO release quenched by ARC. Apoptosis 15:1187-1196
40. Li J, Chen X, Xiao W, Ma W, Li T, Huang J, Liu X, Liang X, Tang S, Luo Y (2011) Mitochondria-targeted antioxidant peptide SS31 attenuates high glucose-induced injury on human retinal endothelial cells. Biochem Biophys Res Commun 404:349-356.
41. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787-795
42. Liu X, Weaver D, Shirihai O, Hajnóczky G (2009) Mitochondrial "kiss-andrun": interplay between mitochondrial motility and fusion-fission dynamics. EMBO J 28:3074-3089.
43. Malik-Hall M, Dina OA, Levine JD (2005) Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci 21:3387-3394
44. Mijnhout GS, Alkhalaf A, Kleefstra N, Bilo HJ (2010) Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes? Neth J Med 68:158-162.
45. Mondal D, Pradhan L, Ali M, Agrawal KC (2004) HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants. Cardiovasc Toxicol 4:287-302
46. Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629-656.
47. Osio M, Muscia F, Zampini L, Nascimbene C, Mailland E, Cargnel A, Mariani C (2006) Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study. J Peripher Nerv Syst 11:72-76
48. Otera H, Mihara K (2011) Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem 149:241-251
49. Pace A, Giannarelli D, Galiè E, Savarese A, Carpano S, Della Giulia M, Pozzi A, Silvani A, Gaviani P, Scaioli V, Jandolo B, Bove L, Cognetti F (2010) Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology 74:762-766
50. Parada CA, Yeh JJ, Joseph EK, Levine JD (2003) Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci 17:1847-1852
51. Peltier AC, Russell JW (2002) Recent advances in drug-induced neuropathies. Curr Opin Neurol 15:633-638.
52. Polomano RC, Bennett GJ (2001) Chemotherapy-evoked painful peripheral neuropathy. Pain Med 2:8-14.
53. Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ (1995) Paclitaxel-induced neuropathy. Ann Oncol 6:489-494
54. Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249:9-17.
55. Risinger AL, Giles FJ, Mooberry SL (2009) Microtubule dynamics as a target in oncology. Cancer Treat Rev 35:255-261
56. Rocha M, Hernandez-Mijares A, Garcia-Malpartida K, Bañuls C, Bellod L, Victor VM (2010) Mitochondria-targeted antioxidant peptides. Curr Pharm Des 16:3124-3131.
57. Rovini A, Savry A, Braguer D, Carré M (2011) Microtubule-targeted agents: when mitochondria become essential to chemotherapy. Biochim Biophys Acta 1807:679-688
58. Saks V, Guzun R, Timohhina N, Tepp K, Varikmaa M, Monge C, Beraud N, Kaambre T, Kuznetsov A, Kadaja L, Eimre M, Seppet E (2010) Structure-function relationships in feedback regulation of energy fluxes in vivo in health and disease: mitochondrial interactosome. Biochim Biophys Acta 1797:678-697
59. Sima A (2007) Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data. CNS Drugs 21 [Suppl 1]:13-23
60. Skjelbakken T, Valen G, Vaage J (1996) Perfusing isolated rat hearts with hydrogen peroxide: an experimental model of cardiac dysfunction caused by reactive oxygen species. Scand J Clin Lab Invest 56:431-439.
61. Skuta G, Fischer GM, Janaky T, Kele Z, Szabo P, Tozser J, Sumegi B (1999) Molecular mechanism of the short-term cardiotoxicity caused by 2',3'-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. Biochem Pharmacol 58:1915-1925
62. Smith RA, Murphy MP (2011) Mitochondria-targeted antioxidants as therapies. Discov Med 11:106-114.
63. Stone JR, Yang S (2006) Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8:243-270
64. Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X (2010) Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 1802:135-142
65. Summer GJ, Romero-Sandoval EA, Bogen O, Dina OA, Khasar SG, Levine JD (2008) Proinflammatory cytokines mediating burn-injury pain. Pain 135:98-107.
66. Tan E, Janssen A, Roestenberg P, van den Heuvel L, Goris R, Rodenburg R (2011) Mitochondrial dysfunction in muscle tissue of complex regional pain syndrome type I patients. Eur J Pain. Advance online publication. Retrieved July 14, 2011. PMID: 21262583.
67. Tanaka A, Youle RJ (2008) A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Mol Cell 29:409-410
68. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22:229-237.
69. Vanotti A, Osio M, Mailland E, Nascimbene C, Capiluppi E, Mariani C (2007) Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies. CNS Drugs 21 [Suppl 1]:3-12
70. Veal EA, Day AM, Morgan BA (2007) Hydrogen peroxide sensing and signaling. Mol Cell 26:1-14
71. Wang JX, Li Q, Li PF (2009) Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1. Cancer Res 69:492-500
72. Westermann B (2010) Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 11:872-884.
73. Wu S, Zhou F, Zhang Z, Xing D (2011) Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J 278:941-954
74. Yu T, Sheu SS, Robotham JL, Yoon Y (2008) Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res 79:341-351
75. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA (2004) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 21:114-121.
76. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R (2006) Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29:2365-2370.